Perspective Therapeutics (CATX) Liabilities from Discontinued Operations (2022 - 2024)

Perspective Therapeutics has disclosed Liabilities from Discontinued Operations across 3 years of filings, most recently posting $5.1 million for Q1 2024.

• In Q1 2024, Liabilities from Discontinued Operations changed N/A year-over-year to $5.1 million; the TTM figure through Mar 2024 stood at $5.1 million (changed N/A YoY), while the FY2023 annual figure was $5.1 million, up 1432.33% from the prior year.
• Liabilities from Discontinued Operations came in at $5.1 million for Q1 2024 at Perspective Therapeutics, roughly flat from $5.1 million in the prior quarter.
• In the past five years, Liabilities from Discontinued Operations ranged from a high of $5.1 million in Q4 2023 to a low of $331000.0 in Q4 2022.
• Average Liabilities from Discontinued Operations over 3 years is $3.5 million, with a median of $5.1 million recorded in 2024.
• The largest YoY upside for Liabilities from Discontinued Operations was 1432.33% in 2023 against a maximum downside of 1432.33% in 2023.
• Over 3 years, Liabilities from Discontinued Operations stood at $331000.0 in 2022, then jumped by 1432.33% to $5.1 million in 2023, then dropped by 0.04% to $5.1 million in 2024.
• Per Business Quant data, the three most recent Liabilities from Discontinued Operations figures were $5.1 million in Q1 2024, $5.1 million in Q4 2023, and $331000.0 in Q4 2022.